The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Showing 1-19 of 19 articles
Coronary interventions
Ten-year outcomes from a randomised comparison of zotarolimus-eluting and sirolimus-eluting stents: the SORT OUT III study
Pareek M, Madsen M, Warnakula Olesen K, Okkels Jensen L, Christiansen E, Dalby Kristensen S, Flensted Lassen J, Thuesen L, Bøtker H, Maeng M
December 6, 2019 | 10.4244/EIJ-D-19-00503
Other coronary interventions
Plaque burden influences accurate classification of fibrous cap atheroma by in vivo optical coherence tomography in a porcine model of advanced coronary atherosclerosis
Poulsen CB, Pedrigi RM, Pareek N, Kilic I, Holm N.R., Bentzon JF, Bøtker H, Falk E, Krams R, De Silva R
November 20, 2018 | 10.4244/EIJ-D-17-01028
STEMI
One-year rehospitalisation after percutaneous coronary intervention: a retrospective analysis
Hansen KN, Bendix K, Antonsen L, Veien K, Maeng M, Junker A, Christiansen E, Kahlert J, Terkelsen C, Christensen LB, Fallesen C, Bøtker H, Okkels Jensen L
October 19, 2018 | 10.4244/EIJ-D-17-00800
Two-year outcome after biodegradable polymer sirolimus- and biolimus-eluting coronary stents (from the randomised SORT OUT VII trial)
Okkels Jensen L, Maeng M, Raungaard B, Hansen K, Kahlert J, Jensen S, Hansen H, Flensted Lassen J, Bøtker H, Christiansen E
January 19, 2018 | 10.4244/EIJ-D-17-00731
Final five-year outcomes after implantation of biodegradable polymer-coated biolimus-eluting stents versus durable polymer-coated sirolimus-eluting stents
Jakobsen L, Christiansen E, Maeng M, Hansen K, Kristensen SD, Bøtker H, Terkelsen C, Jensen S, Raungaard B, Madsen M, Flensted Lassen J, Okkels Jensen L
December 20, 2017 | 10.4244/EIJ-D-17-00434
Coronary interventions
A post hoc analysis of long-term prognosis after exenatide treatment in patients with ST-segment elevation myocardial infarction
Kyhl K, Lønborg J, Vejlstrup N, Kelbæk H, Helqvist S, Holmvang L, Jørgensen E, Saunamäki K, Bøtker H, Clemmensen P, Køber L, Treiman M, Engstrøm T
July 20, 2016 | 10.4244/EIJV12I4A78
Feasibility and early safety of hybrid coronary revascularisation combining off-pump coronary surgery through J-hemisternotomy with percutaneous coronary intervention
Modrau I, Nielsen P, Bøtker H, Christiansen E, Krusell L, Kaltoft A, Terkelsen C, Kristensen SD, Flensted Lassen J, Thuesen L, Maeng M
February 20, 2015 | 10.4244/EIJV10I10A195
ST peak during percutaneous coronary intervention serves as an early prognostic predictor in patients with ST-segment elevation myocardial infarction
Lønborg J, Kelbæk H, Engstrøm T, Helqvist S, Kløvgaard L, Holmvang L, Vejlstrup N, Jørgensen E, Saunamäki K, Dridi N, Kaltoft A, Bøtker H, Clemmensen P, Terkelsen C
August 19, 2014 | 10.4244/EIJV10I4A80
Randomised comparison of manual compression and FemoSeal™ vascular closure device for closure after femoral artery access coronary angiography: the CLOSure dEvices Used in everyday Practice (CLOSE-UP) study
Holm N.R., Sindberg B, Schou M, Maeng M, Kaltoft A, Bottcher M, Krusell L, Hjort J, Thuesen L, Terkelsen C, Christiansen E, Bøtker H, Kristensen SD, Flensted Lassen J
June 20, 2014 | 10.4244/EIJV10I2A31
Outcomes after revascularisation with everolimus- and sirolimus-eluting stents in patients with acute coronary syndromes and stable angina pectoris: a substudy of the SORT OUT IV trial
Antonsen L, Thayssen P, Hansen H, Maeng M, Tilsted H, Bøtker H, Ravkilde J, Madsen M, Sørensen H, Thuesen L, Flensted Lassen J, Okkels Jensen L
June 20, 2014 | 10.4244/EIJV10I2A35
Age- and gender-related changes in plaque composition in patients with acute coronary syndrome: the PROSPECT study
Ruiz-Garc J, Lerman A, Weisz G, Maehara A, Mintz G, Fahy M, Xu K, Lansky A, Cristea E, Farah T, Teles R, Bøtker H, Templin B, Zhang Z, De Bruyne B, Serruys P, Stone G
December 28, 2012 | 10.4244/EIJV8I8A142
Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial
Okkels Jensen L, Maeng M, Thayssen P, Villadsen A, Krusell L, Bøtker H, Pedersen K, Aaroe J, Christiansen E, Vesterlund T, Hansen K, Ravkilde J, Tilsted H, Flensted Lassen J, Thuesen L
July 29, 2011 | 10.4244/EIJV7I3A56
A randomised, double-blind, placebo-controlled, multicentre study of the safety and efficacy of BIOBYPASS (AdGVVEGF121.10NH) gene therapy in patients with refractory advanced coronary artery disease: the NOVA trial
Kastrup J, Jørgensen E, Fuchs S, Nikol S, Bøtker H, Gyöngyösi M, Glogar D, Kornowski R
February 21, 2011
Familial hypercholesterolaemic downsized pig with human-like coronary atherosclerosis: a model for preclinical studies
Thim T, Hagensen M, Drouet L, Sollier C, Bonneau M, Granada J, Nielsen L, Paaske W, Bøtker H, Falk E
June 30, 2010 | 10.4244/EIJV6I2A42
Efficiency and safety of the sirolimus eluting stent in complex coronary artery lesions after cessation of dual antiplatelet therapy: fifteen months clinical outcome of the randomised Stenting Coronary Arteries in Non-stress/benestent Disease (SCANDSTENT) trial
Helqvist S, Kelbæk H, Thuesen L, Kløvgaard L, Krusell L, Jørgensen E, Bøtker H, Jensen G, Flensted Lassen J, Thayssen P, Galloe A, Saunamäki K
November 20, 2007
Impact of drug eluting stents on target vessel revascularization. A report from the Western Denmark heart registry from 2000 to 2004.
Okkels Jensen L, Maeng M, Thayssen P, Flensted Lassen J, Bøtker H, Rasmussen K, Thuesen L
February 20, 2006
Outcome of unprotected left main percutaneous coronary intervention in surgical low-risk, surgical high-risk, and acute myocardial infarction patients
Christiansen E, Flensted Lassen J, Andersen H, Romer Krusell L, Dalby Kristensen S, Bøtker H, Thuesen L
February 20, 2006
Randomized comparison of deliverability and in-hospital complications in implantation of BxSonic®, Express® and Flexmaster® coronary stents
Thuesen L, Galloe A, Thayssen P, Rasmussen K, Kelbæk H, Flensted Lassen J, Hansen P, Pedersen K, Ravkilde J, Helqvist S, Abildgaard U, Andersen H, Bøtker H, Kristensen SD, Hjort J, Romer Krusell L
November 20, 2005
In-laboratory femoral sheath removal after heparin reversal by protamine after percutaneous coronary intervention
Thuesen L, Rud Andersen H, Bøtker H, Kristensen SD, Romer Krusell L, Flensted Lassen J
May 20, 2005

Latest news

NEW ISSUE
Focus on emerging physiology indices, TAVI, sizing with abnormal aortic cusps, a megaregistry of complex PCIs and more…
Tetralogy of Fallot with acquired double right ventricular outflow tract
September 18, 2020
NEW
Device entrapment in chronic total occlusions
September 30, 2020
Editorial
Complex PCI: time for a universal definition
Joanna J. Wykrzykowska
September 30, 2020
JAA
This Week's JAA's: Impact of neoatherosclerosis in ISR on clinical outcome...
September 29, 2020
Spyral, Popular-Tavi, Sort out IX, Solve TAVI, and more
(Released thanks to the support of Biotronik)
September 30, 2020
Editorial
Integrating physiology in OCT
Gianluca Campo
September 23, 2020
Guidance Papers
Guidelines, consensus & position papers
August 28, 2020
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke